Dr. Joel Crawford, MD

Dr. Crawford practices at Sutter Valley Medical Foundation in Roseville, California.

Dr. Crawford's NPI, 1760882401, was assigned on August 31, 2014. Dr. Crawford graduated from Ross University School of Medicine in 2012. Dr. Crawford holds California license A169661.

Dr. Crawford's primary practice is Sutter Valley Medical Foundation, at 3 Medical Plz, Roseville, CA 95661 in Placer County. The practice phone is (800) 470-0071.

Dr. Crawford's primary practice is Sutter Valley Medical Foundation in Roseville, California. Dr. Crawford is also affiliated with Sutter Roseville Medical Center. The medical group on file is SGMF Radiology. Dmand AI also links Dr. Crawford to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Crawford practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Crawford's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Crawford is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Crawford's licenses on file in 5 states: California, Colorado, New Jersey, Pennsylvania and New York.

Dmand AI lists arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, heart device and aorta surgery, leg revascularization, lymphedema, peripheral vascular disease and varicose veins among the conditions Dr. Crawford treats.

CMS data shows 1,263 Medicare services from Dr. Crawford across 16 procedure codes in 2024, for 409 Medicare patients. Medicare paid $155,582 for them.

CMS counts 409 Medicare patients who saw Dr. Crawford in 2024. The largest group is 75 to 84, with 176 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Crawford's median patient age at 74, with 52% women.

In 2024, Dr. Crawford wrote 344 Medicare Part D claims for 131 patients. 94% of them were for generic drugs. CMS names the drug for 278 of them, across 7 drugs with 11 or more claims each, at $20,772 in total drug cost. In 2023, CMS named 234 claims across 6 drugs.

Dr. Crawford accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Crawford as offering telehealth. CMS counts 62 procedures of varicose vein removal by Dr. Crawford, more than 77% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Crawford, published from 2014 to 2023. 2018 was the busiest year, with 2. The most frequent topics are Ablation Techniques, Endovascular Procedures and Practice Patterns, Physicians'. Dr. Crawford has published most often in J Vasc Surg Venous Lymphat Disord. Dr. Crawford's most frequent co-authors are Antonios Gasparis, MD, Sahar Amery, MD and Brajesh Kumar Lal, MD.

CMS Open Payments shows 70 general payments to Dr. Crawford from 17 drug and device companies from 2017 to 2025. Grants make up the largest share, 38% of the total. W. L. Gore & Associates, Inc. paid the most, $4,835.

Dr. Crawford graduated from Ross University School of Medicine in 2012. Dr. Crawford is a member of ACP and ACS.

Dr. Crawford is in network with 13 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.